Literature DB >> 1246803

Gyrate atrophy of the choroid and retina: clinical, ophthalmologic, and biochemical considerations.

C McCulloch, E B Marliss.   

Abstract

A case of gyrate atrophy of the choroid and retina associated with hyperornithinemia has been subjected to extensive clinical and biochemical investigation. The familial occurrence of the ocular disease and of abnormality of amino acid was unique to this 28-year-old male, being absent in parents and siblings. He presented with progressive visual loss, and was found to have cataracts and large areas of peripheral lacunar atrophy. Clinically there was no other abnormality. However, he was hyperuricemic and has an abnormal EEG. Despite otherwise normal biochemical indices of hepatic, renal, and muscle function; selective catheterization of an artery, the hepatic vein, the renal vein, and a deep forearm vein showed all of these circulatory beds to be producing ornithine according to arteriovenous difference measurements. Cerebrospinal fluid and urine contained increased amounts of ornithine. Though electromyography was normal, the muscle biopsy was abnormal. Clinical tests including arginine loading, glucose tolerance testing, and other measurements of blood variables provided inferences as to the metabolic locus of the abnormality. The syndrome is a systemic multiorgan disorder in which the choroid and retina would appear to be target organs and the hyperornithinemia to be of, as yet, undetermined cause and pathogenic significance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1246803      PMCID: PMC1311450     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  10 in total

1.  Amino acid extraction and ammonia metabolism by the human kidney during the prolonged administration of ammonium chloride.

Authors:  E E OWEN; R R ROBINSON
Journal:  J Clin Invest       Date:  1963-02       Impact factor: 14.808

2.  Hyperornithinemia, hyperammonemia, and homocitrullinuria associated with decreased carbamyl phosphate synthetase I activity.

Authors:  P D Gatfield; E Taller; D M Wolfe; M D Haust
Journal:  Pediatr Res       Date:  1975-05       Impact factor: 3.756

3.  Genetic aspects in gyrate atrophy of the choroid and retina with hyperornithinaemia.

Authors:  K Takki; O Simell
Journal:  Br J Ophthalmol       Date:  1974-11       Impact factor: 4.638

4.  Gyrate atrophy of the choroid and retina associated with hyperornithinaemia.

Authors:  K Takki
Journal:  Br J Ophthalmol       Date:  1974-01       Impact factor: 4.638

5.  Tubular aggregates in type II muscle fibers: ultrastructural and histochemical correlation.

Authors:  W K Engel; D W Bishop; G G Cunningham
Journal:  J Ultrastruct Res       Date:  1970-06

6.  [Ornithinemia, additional disorder of amino acid metabolism with brain damage].

Authors:  H Bickel; D Feist; H Müller; G Quadbeck
Journal:  Dtsch Med Wochenschr       Date:  1968-11-22       Impact factor: 0.628

7.  Amino acid metabolism in the regulation of gluconeogenesis in man.

Authors:  P Felig; E Marliss; T Pozefsky; G F Cahill
Journal:  Am J Clin Nutr       Date:  1970-07       Impact factor: 7.045

8.  Amino acid metabolism during prolonged starvation.

Authors:  P Felig; O E Owen; J Wahren; G F Cahill
Journal:  J Clin Invest       Date:  1969-03       Impact factor: 14.808

9.  Ornithine-ketoacid aminotransferase in human liver with reference to patients with hyperornithinaemia and familial protein intolerance.

Authors:  M P Kekomäki; N C Räihä; H Bickel
Journal:  Clin Chim Acta       Date:  1969-01       Impact factor: 3.786

10.  Studies on the development of ornithine-keto acid aminotransferase activity in rat liver.

Authors:  N C Räihä; M P Kekomäki
Journal:  Biochem J       Date:  1968-07       Impact factor: 3.857

  10 in total
  5 in total

1.  Treatment of gyrate atrophy of the choroid and retina with low arginine diet.

Authors:  R R McInnes; S A Arshinoff; L Bell; C McCulloch
Journal:  Trans Am Ophthalmol Soc       Date:  1980

2.  Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia.

Authors:  M Valtonen; K Näntö-Salonen; S Jääskeläinen; K Heinänen; A Alanen; O J Heinonen; N Lundbom; M Erkintalo; O Simell
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

3.  Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation.

Authors:  Agnes B Renner; Andreas Walter; Britta S Fiebig; Herbert Jägle
Journal:  Doc Ophthalmol       Date:  2012-06-07       Impact factor: 2.379

4.  Biochemical and therapeutical studies in a case of atrophia gyrata.

Authors:  W Behrens-Baumann; U König; K Schröder; I Hansmann; U Langenbeck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

5.  Gyrate atrophy of the choroid and retina with reticular pigmentary dystrophy and ornithine-ketoacid-transaminase deficiency.

Authors:  A F Deutman; R C Sengers; J M Trybels
Journal:  Int Ophthalmol       Date:  1978-09       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.